Drug Price Increases That Exceed Inflation Are Costing Medicare Part D Billions

This AARP Public Policy Institute Spotlight finds that total Medicare Part D spending on 50 top brand-name drugs was $38 billion higher between 2015 and 2019 than it would have been if drug manufac...
Source: AARP.org News - Category: American Health Source Type: news